Antidepressant combination for major depression in incomplete responders - A systematic review

Journal of Affective Disorders

Volumn 144, Issue 1-2, 2013, Pages 1-6

  Lopes Rocha, Fábio ^a   Fuzikawa, Cíntia ^b   Riera, Rachel ^c   Ramos, Melissa Guarieiro ^d   Hara, Cláudia ^e  

^a Instituto de Previdencia Dos Servidores do Estado de Minas Gerais IPSEMG   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Interdisciplinar Center for Research and Assistance on Aging   (Brazil)

^e Faculdade da Saúde e Ecologia Humana FASEH Vespasiano   (Brazil)

Author keywords

Antidepressant agents; Combination drug therapy; Major depressive disorder; Treatment resistance

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; APPETITE STIMULANT; DESIPRAMINE; FLUOXETINE; LITHIUM; MIANSERIN; MIRTAZAPINE; PLACEBO; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGITATION; ANOREXIA; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; EFFECT SIZE; FATIGUE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DESIPRAMINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84870300315     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.04.048     Document Type: Review

References (26)

1. M. Bauer, and T. Bschor World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care World Journal Of Biological Psychiatry 8 2 2007 67 104
2. L.L. Carpenter, and S. Yasmin A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine Biological Psychiatry 51 2 2002 183 188
3. N. Casacalenda, and J.C. Perry Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions The American Journal of Psychiatry 159 8 2002 1354 1360
4. S. Dodd, and D. Horgan To combine or not to combine? A literature review of antidepressant combination therapy Journal of Affective Disorders 89 1-3 2005 1 11
5. R.S. El-Mallakh, and G. Kaur Placebo group needed for interpretation of combination trial The American Journal of Psychiatry 167 8 2010 996
6. M. Fava, and J. Alpert Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. Journal of Clinical Psychopharmacology 22 4 2002 379 387
7. M. Fava, and J.F. Rosenbaum Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study The American Journal of Psychiatry 151 9 1994 1372 1374
8. M. Ferreri, and F. Lavergne Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone Acta Psychiatrica Scandinavica 103 1 2001 66 72
9. J.P. Higgins, and S.G. Thompson Measuring inconsistency in meta-analyses BMJ (Clinical Research Edition) 327 7414 2003 557 560
10. J.P.T. Higgins, and S. Green Cochrane Book Series 2008 John Wiley & Sons Ltd. Chichester
11. M.B. Keller Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA: The Journal of the American Medical Association 289 23 2003 3152 3160
12. L. Lauritzen, and L. Clemmesen Combined treatment with imipramine and mianserin. A controlled pilot study Pharmacopsychiatry 25 4 1992 182 186
13. R.W. Licht, and S. Qvitzau Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation Psychopharmacology (Berlin) 161 2 2002 143 151
14. M. Maes, and I. Libbrecht Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance Journal of Clinical Psychopharmacology 19 2 1999 177 182
15. M. Maes, and E. Vandoolaeghe Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression Journal of Affective Disorders 41 3 1996 201 210
16. A. Medhus, and S. Heskestad Mianserin added to tricyclic antidepressants in depressed patients not responding to a tricyclic antidepressant alone: A randomized, placebo-controlled, double-blind study. Nordic Journal of Psychiatry 48 5 1994 355 358
17. J.E. Murphy A comparative trial of Anafranil, Pertofran and an Anafranil/Pertofran combination The Journal of International Medical Research 5 1 Suppl 1977 16 23
18. S. O'Brien, and P. McKeon The efficacy and tolerability of combined antidepressant treatment in different depressive subgroups The British Journal of Psychiatry: The Journal of Mental Science 162 1993 363 368
19. H.E. Pigott, and A.M. Leventhal Efficacy and effectiveness of antidepressants: current status of research. Psychotherapy and Psychosomatics 79 5 2010 267 279
20. R.M. Pinder, and A.M. Van Delft The potential therapeutic role of the enantiomers and metabolites of mianserin British Journal of Clinical Pharmacology 15 Suppl 2 1983 269S 276S
21. F.L. Rocha, and C. Fuzikawa Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis. Journal of Clinical Psychopharmacology 32 2 2012 278 281
22. A.J. Rush Combining antidepressant medications: a good idea? The American Journal of Psychiatry 167 3 2010 241 243
23. A.J. Rush, and M.H. Trivedi Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report The American Journal of Psychiatry 163 11 2006 1905 1917
24. D. Smith, and C. Dempster Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. The British Journal of Psychiatry 180 5 2002 396 404
25. M.E. Thase Antidepressant combinations: widely used, but far from empirically validated Canadian Journal of Psychiatry Revue Canadienne De Psychiatrie 56 6 2011 317 323
26. S. Vezmar, and B. Miljkovic Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression. Journal of Pharmacological Sciences 110 1 2009 98 104